Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000037

CEO bought 34,000 shares at an average $0.01 ($425)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-04 Purchase : show line 1 in the form +10,000 $0.01 $130 24,167,097 D
2019-06-04 Purchase : show line 2 in the form +1,000 $0.01 $13 24,168,097 D
2019-06-04 Purchase : show line 3 in the form +2,000 $0.01 $26 24,170,097 D
2019-06-04 Purchase : show line 4 in the form +1,000 $0.01 $12 24,171,097 D
2019-06-04 Purchase : show line 5 in the form +15,000 $0.01 $183 24,186,097 D
2019-06-04 Purchase : show line 6 in the form +5,000 $0.01 $62 24,191,097 D
Open-market purchases · 34,000 sh · avg $0.01 · $425
Loading xslF345X03/primary_doc.xml…